ANEW Medical EBITDA 2023-2024 | KLTO
ANEW Medical ebitda from 2023 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
ANEW Medical Annual EBITDA
(Millions of US $) |
ANEW Medical Quarterly EBITDA
(Millions of US $) |
| 2024-06-30 |
|
| 2022-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.016B |
$0.000B |
|
ANEW MEDICAL INC. specializes in the development of diagnostics and novel disease-modifying therapies for neurological and age-related disorders. The company's focus on central nervous systems diseases utilizing cell and gene therapies to mitigate age-related pathologies such as Alzheimer's disease, dementia symptoms and neuromuscular diseases. ANEW MEDICAL INC., formerly known as REDWOODS ACQ, is based in NEW YORK.
|
